Last Price | 241.00 | Max Price | 248.50 |
Min Price | 171.40 | 1 Year return | 6.64 |
Avg. Target | 0.00 | Expected Return | - |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Sell | 0 | Rating | |
Hold | 0 | Concensus | |
Buy | 0 |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 10 | 1,914,856 | 0.00 % |
2020 | 6 | 1,909,941 | 0.00 % |
2021 | 10 | 2,244,427 | 0.00 % |
2022 | 12 | 2,638,646 | 0.00 % |
2023 | 14 | 2,748,111 | 0.00 % |
No Records Found
No Records Found
No Records Found
Over the last 12 months (from December 2015 till December 2016), that were profitable period for the investors in Spire Healthcare Group PLC, the stock gained around 14 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 0 percent. Spire Healthcare Group PLC's revenues between 2011 and 2015 were relatively stable and moved between 73,89 billion GBp and 88,48 billion GBp. Spire Healthcare Group PLC's net results between 2011 and 2015 were far from constant and moved between -1984 million GBp and 8,26 billion GBp.
The past 10 years the (international) industry gained at around 102 percent. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
The English company paid out dividends in the past 5 years. Over the past 5 years the stock delivered an average dividend return of 4,2 percent. Spire Healthcare Group PLC raised it's dividends per share each year in the past 5 years. So we could call Spire Healthcare Group PLC a kind of dividend aristocrat.
At the end of 2015 the health care company's balance sheet equaled 165,72 billion GBp. Of the total balance sheet 65,96 billion GBp (39,8 percent) was financed by debt.
At the end of 2015 the English company had around 399,89 million stocks listed.
All the company's financial reports are available here. More information about Spire Healthcare Group PLC can be found it's website. .
Results |
2021
|
2022
|
2023
|
2024
|
2025
|
---|---|---|---|---|---|
Revenue |
|
|
|
|
|
Costs |
|
|
|
|
|
Profit |
|
|
|
|
|
Margin of profit |
|
|
|
|
|
ROI |
|
|
|
|
|
Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
---|---|---|---|---|---|
Equity |
|
|
|
|
|
Debt |
|
|
|
|
|
Total assets |
|
|
|
|
|
Solvency |
|
|
|
|
|
Cash |
|
|
|
|
|
Cashflow |
|
|
|
|
|
Employees |
|
|
|
|
|
Revenue per employee |
|
|
|
|
|
Cashflow / Debt |
|
|
|
|
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
337.70
|
253.60
|
108.90
|
142.00
|
155.40
|
Eps |
0.13
|
0.04
|
0.0
|
0.02
|
-0.58
|
Price/earnings-ratio |
2597.69
|
6340.00
|
0.0
|
7100.00
|
-415.52
|
Dividend |
0.04
|
0.04
|
0.04
|
0.01
|
|
Dividend % |
0.01 %
|
0.02 %
|
0.04 %
|
0.01 %
|
|
Payout % |
0.31
|
1.00
|
0.0
|
0.50
|
|
Book value |
0.03
|
0.03
|
0.02
|
0.02
|
0.02
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.01
|
|
Stocks |
401
|
401
|
401
|
401
|
401
|
Market Cap |
135.445.19
|
101.714.24
|
43.677.72
|
56.953.50
|
96.660.52
|
Date
|
Price
|
---|---|
03 Oct 2025
|
241.00
|
30 Sep 2025
|
248.50
|
22 Sep 2025
|
235.50
|
16 Sep 2025
|
208.00
|
08 Sep 2025
|
213.00
|
01 Sep 2025
|
217.00
|
21 Aug 2025
|
224.50
|
15 Aug 2025
|
225.00
|
07 Aug 2025
|
213.00
|
23 Jul 2025
|
225.00
|
18 Jul 2025
|
225.00
|
17 Jul 2025
|
225.00
|
16 Jul 2025
|
220.50
|
15 Jul 2025
|
222.00
|
14 Jul 2025
|
223.50
|
11 Jul 2025
|
222.00
|
10 Jul 2025
|
224.50
|
09 Jul 2025
|
220.00
|
08 Jul 2025
|
221.00
|
07 Jul 2025
|
226.50
|
04 Jul 2025
|
228.00
|
03 Jul 2025
|
227.00
|
02 Jul 2025
|
223.50
|
01 Jul 2025
|
227.00
|
30 Jun 2025
|
224.00
|
27 Jun 2025
|
225.50
|
26 Jun 2025
|
224.00
|
25 Jun 2025
|
217.00
|
24 Jun 2025
|
213.00
|
23 Jun 2025
|
210.00
|